AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’
Pascal Soriot is AstraZeneca’s chief executive and the highest-paid leader of a FTSE 100 company. Photograph: Kent Nishimura/ReutersView image in fullscreenPascal Soriot is AstraZeneca’s chief executive and the highest-paid leader of a FTSE 100 company. “What we are learning ourselves is we have to move much faster.
- ▪Pascal Soriot is AstraZeneca’s chief executive and the highest-paid leader of a FTSE 100 company.
- ▪Photograph: Kent Nishimura/ReutersView image in fullscreenPascal Soriot is AstraZeneca’s chief executive and the highest-paid leader of a FTSE 100 company.
- ▪“What we are learning ourselves is we have to move much faster.
The Guardian — World publishes from United Kingdom and files mainly under world. We currently carry 2,204 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | World news | The Guardian |
| Canonical URL | https://www.theguardian.com/business/2026/jul/27/astrazeneca-boss-urges-western-drugmakers-to-move-at-chinese-speed |
| Publication time | Mon, 27 Jul 2026 12:09:41 GMT |
| Retrieval time | 2026-07-27T12:16:17.642Z |
| Last seen | 2026-07-27T12:16:17.642Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | hxVtSsDwbK1h · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Pascal Soriot is AstraZeneca’s chief executive and the highest-paid leader of a FTSE 100 company. Photograph: Kent Nishimura/ReutersView image in fullscreenPascal Soriot is AstraZeneca’s chief executive and the highest-paid leader of a FTSE 100 company. Photograph: Kent Nishimura/ReutersAstraZenecaAstraZeneca boss urges western drugmakers to move at ‘Chinese speed’Europe and US risk being outpaced on innovation, as happened in the car industry, warns Pascal SoriotJasper JollyMon 27 Jul 2026 08.09 EDTLast modified on Mon 27 Jul 2026 08.12 EDTSharePrefer the Guardian on GoogleAstraZeneca must operate at “Chinese speed” to ensure it doesn’t suffer the fate of the western automotive industry by losing out to more innovative rivals, the drug company’s boss has said.The FTSE 100 company is…
Excerpt limited to ~120 words for fair-use compliance. The full article is at World news | The Guardian.
Discussion
0 commentsMore from World news | The Guardian
